Coexisting adult polyglucosan body disease with frontotemporal lobar degeneration with transactivation response DNA-binding protein-43 (TDP-43)-positive neuronal inclusions

Neurocase

Volumn 19, Issue 1, 2013, Pages 67-75

  Farmer, Jill G ^a   Crain, Barbara J ^b   Harris, Brent T ^a   Turner, R Scott ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dementia; Frontotemporal lobar degeneration; Neuropathology; Polyglucosan body disease; TDP 43; Transactivation response DNA binding protein 43; Ubiquitin

Indexed keywords

GADOLINIUM; TAR DNA BINDING PROTEIN; UBIQUITIN;

ADULT; ADULT POLYGLUCOSAN BODY DISEASE; APRAXIA; ARTICLE; BRAIN ATROPHY; CASE REPORT; CELL LOSS; DEMENTIA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTELLIGENCE QUOTIENT; METABOLIC DISORDER; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLOR; TRANSACTIVATION;

ACTIVITIES OF DAILY LIVING; BRAIN; DNA-BINDING PROTEINS; FATAL OUTCOME; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; GLUCANS; HUMANS; INCLUSION BODIES; JEWS; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEURONS; NEUROPSYCHOLOGICAL TESTS; TRANSCRIPTIONAL ACTIVATION;

EID: 84872398744     PISSN: 13554794     EISSN: 14653656     Source Type: Journal    
DOI: 10.1080/13554794.2011.654217     Document Type: Article

References (9)

1. Berkhoff, M., Weiss, J., Schroth, G. and Sturzenegger, M. 2001. Extensive white-matter changes in case of adult polyglucosan body disease. Neuroradiology, 43: 234-236.
2. Boulan-Predseil, P., Vital, A., Brochet, B., Darriet, D, Henry, P.Vital, C. 1995. Dementia of frontal lobe type due to adult polyglucosan disease. Journal of Neurology, 242: 512-516.
3. Cairns, N. J., Bigio, E. H., Mackenzie, I. R., Neumann, M., Lee, V. M.-Y.Hatanpaa, K. J. 2007a. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathologica, 114: 5-22.
4. Cairns, N. J., Neumann, M., Bigio, E. H., Holm, I. E., Troost, D.Hatanpaa, K. J. 2007b. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. American Journal of Pathology, 171: 227-240.
5. Chen-Plotkin, A. S., Lee, V. M.-Y. and Trojanowski, J. Q. 2010. TAR DNA-binding protein 43 in neurodegenerative disease. Nature Reviews Neurology, 6: 211-220.
6. Davidson, Y., Kelley, T., Mackenzie, I. R., Pickering-Brown, S., Du Plessis, D.Neary, D. 2007. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TBP-43. Acta Neuropathologica, 113: 521-533.
7. Mackenzie, I. R., Neumann, M, Bigio, E. H., Cairns, N. J., Alafuzoff, I.Kril, J. 2010. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: An update. Acta Neuropathologica, 119: 1-4.
8. Milde, P., Guccion, J. G., Kelly, J., Locatelli, E. and Jones, R. 2001. Adult polyglucosan body disease. Archives of Pathology and Laboratory Medicine, 125: 519-522.
9. Sindern, E., Ziemssen, F., Ziemssen, T., Podskarbi, T., Shin, Y.Brasch, F. 2003. Adult polyglucosan body disease. A postmortem correlation study. Neurology, 61: 263-265.